Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Serum exosomal hsa-circ-0004771 modulates the resistance of colorectal cancer to 5-fluorouracil via regulating miR-653/ZEB2 signaling pathway

Fig. 2

Hsa-circ-0004771 was up-regulated in serum exosomes and associated with 5-FU resistance in CRC patients. A qRT-PCR showing the relative expression level of hsa-circ-0004771 in serum exosomes from CRC (pre-treatment) and BID patients, and HC cases (* (CRC vs BID), P < 0.05; ### (HC vs CRC), P < 0.001). B qRT-PCR showing the relative expression level of hsa-circ-0004771 in serum exosomes from 5-FU resistant and sensitive CRC (after finish of chemotherapy with 5-FU) patients, and HC cases. $ (5-FU-resistant CRC vs 5-FU-sensitive CRC), P < 0.05; ** (5-FU-resistant CRC vs HC), P < 0.01; # (5-FU-sensitive CRC vs HC), P < 0.05. CRC colorectal cancer, BID benign intestinal disease, HC healthy control; 5-FU: 5-fluorouracil

Back to article page